Melatonin Market at Crossroads
A recent study suggests that long-term use of melatonin—defined as exceeding 12 months—may increase the risks of heart failure and mortality among individuals suffering from chronic insomnia. Although the melatonin industry is valued at approximately $2.5 to $3 billion annually and is widely used, the latest findings have raised concerns about the safety of prolonged use, especially as reliance on it as a natural alternative to sleeping medications is on the rise. Studies indicate that long-term melatonin users are about 90% more likely to develop heart failure compared to non-users, with higher rates of hospitalization and death—though these studies do not establish a direct causal relationship. The issue remains that patients turning to supplements may already be at increased risk for other health problems, and there are challenges related to product regulation and quality. This industry now faces a critical test; being a massive market, its future could be reshaped if genuine health risks are confirmed.
Notice: This Is an AI-Generated Summary
Comments (0)